38 related articles for article (PubMed ID: 22257092)
1. TGF-β1 -509C/T polymorphism and susceptibility to keloid disease: a systematic review and meta-analysis.
Tu Y; Lineaweaver WC; Zhang F
Scars Burn Heal; 2017; 3():2059513117709943. PubMed ID: 29799568
[TBL] [Abstract][Full Text] [Related]
2. Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease.
Cai X; Zha H; Yang Z; Du Y; Dai X; Yang B; Wang J; He Q; Weng Q
Front Immunol; 2022; 13():1058532. PubMed ID: 36466817
[TBL] [Abstract][Full Text] [Related]
3. Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.
Wang C; Gong J; Wu H
Biomed Rep; 2017 Aug; 7(2):95-104. PubMed ID: 28804621
[TBL] [Abstract][Full Text] [Related]
4. Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis.
Lu WQ; Qiu JL; Huang ZL; Liu HY
Oncotarget; 2016 Dec; 7(51):84695-84704. PubMed ID: 27835897
[TBL] [Abstract][Full Text] [Related]
5. Human genetic variation and the risk of hepatocellular carcinoma development.
Ezzikouri S; Benjelloun S; Pineau P
Hepatol Int; 2013 Jul; 7(3):820-31. PubMed ID: 26201919
[TBL] [Abstract][Full Text] [Related]
6. Lack of Association of Tumor Necrosis Factor-α G-308A and Transforming Growth Factor-β1 C-509T Polymorphisms in Patients with Deep Neck Space Infections.
Jevtović-Stoimenov T; Despotović M; Pešić Z; Cosić A
Balkan J Med Genet; 2013 Dec; 16(2):59-66. PubMed ID: 24778565
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk.
Li W; Wu H; Song C
Tumour Biol; 2013 Oct; 34(5):2675-81. PubMed ID: 23653379
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β genetic polymorphisms on development of liver cirrhosis in a meta-analysis.
Wu XD; Zeng K; Gong CS; Chen J; Chen YQ
Mol Biol Rep; 2013 Jan; 40(1):535-43. PubMed ID: 23104471
[TBL] [Abstract][Full Text] [Related]
9. Association of transforming growth factor-β1 T869C, G915C, and C509T gene polymorphisms with rheumatoid arthritis risk.
Zhou TB; Zhao HL; Fang SL; Drummen GP
J Recept Signal Transduct Res; 2014 Dec; 34(6):469-75. PubMed ID: 24840097
[TBL] [Abstract][Full Text] [Related]
10. Association between transforming growth factor-β1 polymorphisms and hepatocellular cancer risk: A meta-analysis.
Xiang TX; Cheng N; Li XN; Wu XP
Hepatol Res; 2012 Jun; 42(6):583-90. PubMed ID: 22257092
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer's disease.
Chang WW; Zhang L; Jin YL; Yao YS
J Neural Transm (Vienna); 2013 Feb; 120(2):353-60. PubMed ID: 22782686
[TBL] [Abstract][Full Text] [Related]
13. The transforming growth factor-β1 (TGF-β1) gene polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and susceptibility to postmenopausal osteoporosis: a meta-analysis.
Sun J; Zhang C; Xu L; Yang M; Yang H
Medicine (Baltimore); 2015 Jan; 94(4):e461. PubMed ID: 25634187
[TBL] [Abstract][Full Text] [Related]
14. Association between transforming growth factor-β1 -509 C>T variants and hepatocellular carcinoma susceptibility: a meta-analysis.
Toshikuni N; Matsue Y; Minato T; Hayashi N; Tsutsumi M
Neoplasma; 2016; 63(6):961-966. PubMed ID: 27596296
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
